Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs MDxHealth SA (MDXH)

Insight Molecular Diagnostics Inc. and MDxHealth SA are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $100.1M against $57.6M — 1.7× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −60.8%. MDxHealth SA has the higher net margin (−32.5% vs −2,955.6%) and the lower return on invested capital (−23.8% vs 0.00%). Across the 17 metrics below, MDxHealth SA leads on 11 and Insight Molecular Diagnostics Inc. on 6.

Valuation

Metric IMDX MDXH Diagnostics & Research median
P/E n/m n/m 35.56
P/S 66.24 0.10 4.37
P/B n/m n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 55.72 0.84 5.51
Earnings yield (49.50%) (342.86%) (1.89%)
Free cash flow yield (28.02%) (63.49%) (0.15%)

Profitability

Metric IMDX MDXH Diagnostics & Research median
Gross margin 48.32% 63.23% 50.89%
Operating margin (3,011.86%) (18.04%) (8.57%)
Net margin (2,955.63%) (32.53%) (6.37%)
Free cash flow margin (1,856.23%) (5.24%) 0.00%
Return on equity 488.68% 238.67% (2.92%)
Return on assets (123.46%) (27.38%) (6.71%)
Return on invested capital 0.00% (23.77%) 0.00%

Growth

Metric IMDX MDXH Diagnostics & Research median
Revenue growth (TTM) (60.77%) 21.46% 7.69%
EPS growth (last fiscal year) 64.59% 42.24% 25.92%
Revenue growth, 5-year CAGR 27.24% 42.34% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX MDXH Diagnostics & Research median
Debt to equity (0.04) (3.42) 0.11
Current ratio 2.00 1.15 2.02
Net debt to EBITDA (0.67) (10.71) 0.70

Dividend

Metric IMDX MDXH Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IMDX MDXH Diagnostics & Research median
Market cap 100.14m 57.60m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack